1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azukizawa, S; Fukui, M; Kawahara, A; Kitao, T; Otake, K; Shirahase, H; Takeda, S | 1 |
1 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Novel 2,7-Substituted (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acids: Peroxisome Proliferator-Activated Receptor γ Partial Agonists with Protein-Tyrosine Phosphatase 1B Inhibition.
Topics: Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred Strains; Molecular Structure; PPAR gamma; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Tetrahydroisoquinolines | 2015 |